Stay updated on Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with California (Los Angeles) at Cedars-Sinai Medical Center and updated the page revision to v3.3.3. The older California Locations entry, HHS Vulnerability Disclosure, and the prior v3.3.2 reference were removed.
    Difference
    0.2%
    Check dated 2025-12-23T13:37:18.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The Study Record Dates now shows 'Last Update Posted (Estimated)' with new dates (2025-11-14, 2025-12-02). The previous generic 'Last Update Posted' label was removed.
    Difference
    0.3%
    Check dated 2025-12-09T01:20:39.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T19:02:26.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Removed the site-wide funding-status notice about government funding lapses, which previously informed users that data may be out of date and inquiries might be delayed. The page's study details and eligibility information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T18:06:08.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    No substantive content changes were detected; the page continues to present the study overview, eligibility criteria, and planned outcomes for the Pembrolizumab + Olaparib trial. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T12:36:28.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    3%
    Check dated 2025-10-05T17:32:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page.